CLLSA is a member of Cancer52 – a group dedicated to furthering the cause of rarer and less common cancers.
Cancer52 is currently conducting a piece of work to help inform their contribution to any new Cancer Strategy that will follow the existing one, which runs until 2020/2021. To help inform their contribution they are looking at all the issues facing people with rare and less common cancers and consider what needs to improve.
They now want to hear from people who are living with or have had a rare or less common cancer, as well as carers, about their experiences and how they think the experiences of future patients could be improved. It will help to show the government and the people who run the NHS what people with a rare or less common cancer think needs to change.
The closing date is 22 August.
The Board of Trustees – CLLSA